[{"id":"bf503cc8-5a00-475d-beaf-00424c53ee90","acronym":"","url":"https://clinicaltrials.gov/study/NCT00730158","created_at":"2021-01-18T02:45:00.417Z","updated_at":"2024-07-02T16:36:59.400Z","phase":"Phase 2","brief_title":"A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal Cancer","source_id_and_acronym":"NCT00730158","lead_sponsor":"Edward Chu, MD","biomarkers":" KRAS","pipe":" | ","alterations":" KRAS mutation • KRAS wild-type","tags":["KRAS"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KRAS mutation • KRAS wild-type"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e irinotecan • YIV-906"],"overall_status":"Completed","enrollment":" Enrollment 33","initiation":"Initiation: 12/01/2008","start_date":" 12/01/2008","primary_txt":" Primary completion: 06/01/2016","primary_completion_date":" 06/01/2016","study_txt":" Completion: 06/01/2018","study_completion_date":" 06/01/2018","last_update_posted":"2019-05-22"}]